1995
DOI: 10.1002/jlcr.2580370501
|View full text |Cite
|
Sign up to set email alerts
|

Eleventh international symposium on radiopharmaceutical chemistry: Abstracts

Abstract: Aniracetam ( I-p-anisoyl-2-pyrrolidinone) is one of the piracetam-like nootropics which exhibit memory enhancing properties1 . Although the therapeutic potentials of aniracetam in patients with senile cognitive disorders such as Alzheimer's disease has been evaluated2 and this drug is now used in clinical trials in Europe, the mechanism of action is not fully understood. Recently, aniracetam has been shown to increase the conductance of a-amino-3-hydroxy-5methyl4isoxazole propionate (AMPA) receptor, but not to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 94 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?